RP 705 (Amphetamine and Dextroamphetamine Extended Release 5 mg)
Pill with imprint RP 705 is Blue / Beige, Capsule-shape and has been identified as Amphetamine and Dextroamphetamine Extended Release 5 mg. It is supplied by Rhodes Pharmaceuticals.
Amphetamine/dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Amphetamine/dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RP 705
Amphetamine and Dextroamphetamine Extended Release
- Imprint
- RP 705
- Strength
- 5 mg
- Color
- Blue / Beige
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Rhodes Pharmaceuticals
- National Drug Code (NDC)
- 42858-0055
More about amphetamine / dextroamphetamine
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 873 Reviews
- Drug class: CNS stimulants
- FDA Alerts (3)
Consumer resources
- Patient Information
- Dextroamphetamine and amphetamine (Advanced Reading)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
- Dextroamphetamine and Amphetamine Tablets
- Other brands
- Adderall, Adderall XR, Mydayis
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.